Your browser doesn't support javascript.
loading
Evaluating the Use of KIM-1 in Drug Development and Research Following FDA Qualification.
Chen, Ru; Sanyal, Sarmistha; Thompson, Aliza; Ix, Joachim H; Haskins, Kylie; Muldowney, Laurie; Amur, Shashi.
Afiliación
  • Chen R; Immediate Office, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Sanyal S; Immediate Office, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Thompson A; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Ix JH; Division of Nephrology-Hypertension, School of Medicine, University of California San Diego, La Jolla, California, USA.
  • Haskins K; Immediate Office, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Muldowney L; Immediate Office, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
  • Amur S; Immediate Office, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Clin Pharmacol Ther ; 104(6): 1175-1181, 2018 12.
Article en En | MEDLINE | ID: mdl-29761868
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Aprobación de Drogas / Biomarcadores Farmacológicos / Lesión Renal Aguda / Receptor Celular 1 del Virus de la Hepatitis A / Desarrollo de Medicamentos Tipo de estudio: Diagnostic_studies / Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies Límite: Animals / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: United States Food and Drug Administration / Aprobación de Drogas / Biomarcadores Farmacológicos / Lesión Renal Aguda / Receptor Celular 1 del Virus de la Hepatitis A / Desarrollo de Medicamentos Tipo de estudio: Diagnostic_studies / Etiology_studies / Evaluation_studies / Observational_studies / Prognostic_studies Límite: Animals / Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Pharmacol Ther Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos